-
EP1148882
European procedure
Extract from the Register of European Patents
EP About this file: EP1148882
| EP1148882 - USE OF A PLASMA HOMOCYSTEINE CONTENT REDUCING AGENT FOR THE REDUCTION OF THE THROMBOEMBOLIC SIDE EFFECT RISK INDUCED BY GESTAGEN TYPE HORMONES [Right-click to bookmark this link] | |||
| Former [2001/44] | PHARMACEUTICAL COMBINATION OF PROGESTERONE AND FOLIC ACID | ||
| [2006/44] | Status | No opposition filed within time limit Status updated on 06.06.2008 Database last updated on 19.07.2024 | Most recent event Tooltip | 15.11.2013 | Lapse of the patent in a contracting state | published on 18.12.2013 [2013/51] | Applicant(s) | For all designated states Bogye, Gabor Frankel Leo u. 7 1027 Budapest / HU | [2001/44] | Inventor(s) | 01 /
see applicant ... | [2001/44] | Representative(s) | Beetz & Partner mbB Patentanwälte Prinzregentenstraße 54 80538 München / DE | [N/P] |
| Former [2001/44] | Beetz & Partner Patentanwälte Steinsdorfstrasse 10 80538 München / DE | Application number, filing date | 00903916.5 | 28.01.2000 | [2001/44] | WO2000HU00009 | Priority number, date | HU19990000213 | 01.02.1999 Original published format: HU 9900213 | [2001/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0044385 | Date: | 03.08.2000 | Language: | EN | [2000/31] | Type: | A1 Application with search report | No.: | EP1148882 | Date: | 31.10.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.08.2000 takes the place of the publication of the European patent application. | [2001/44] | Type: | B1 Patent specification | No.: | EP1148882 | Date: | 01.08.2007 | Language: | EN | [2007/31] | Search report(s) | International search report - published on: | EP | 03.08.2000 | Classification | IPC: | A61K31/519, A61K31/57, A61K31/4415, A61P7/02 | [2006/44] | CPC: |
A61K31/57 (EP);
A61K31/14 (EP);
A61K31/198 (EP);
A61K31/205 (EP);
A61K31/4415 (EP);
A61K31/519 (EP);
| C-Set: |
A61K31/14, A61K2300/00 (EP);
A61K31/198, A61K2300/00 (EP);
A61K31/205, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/519, A61K31/57 (EP);
A61K31/57, A61K2300/00 (EP);
A61K31/57, A61K31/14 (EP);
A61K31/57, A61K31/195 (EP);
A61K31/57, A61K31/205 (EP);
A61K31/57, A61K31/44 (EP);
A61K31/57, A61K31/505 (EP);
A61K31/66, A61K2300/00 (EP);
A61K31/66, A61K31/57 (EP); |
| Former IPC [2001/44] | A61K31/505, A61K31/57 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/44] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERWENDUNG EINES DEN PLASMA HOMOCYSTEINGEHALT REDUZIERENDEN WIRKSTOFFS ZUR VERMINDERUNG DES RISIKOS DER DURCH GESTAGEN HORMONE VERURSACHTEN THROMBOEMBOLISCHEN NEBENWIRKUNGEN | [2006/47] | English: | USE OF A PLASMA HOMOCYSTEINE CONTENT REDUCING AGENT FOR THE REDUCTION OF THE THROMBOEMBOLIC SIDE EFFECT RISK INDUCED BY GESTAGEN TYPE HORMONES | [2006/44] | French: | UTILISATION D'UN AGENT REDUISANT LA TENEUR EN HOMOCYSTEINE DANS LE PLASMA POUR LA REDUCTION DU RISQUE D'EFFETS SECONDAIRES THROMBOEMBOLIQUES INDUITS PAR LES HORMONES GESTAGENES | [2006/44] |
| Former [2001/44] | PHARMAZEUTISCHE KOMBINATION ENTHALTEND PROGESTERON UND FOLSÄURE | ||
| Former [2001/44] | PHARMACEUTICAL COMBINATION OF PROGESTERONE AND FOLIC ACID | ||
| Former [2001/44] | COMBINAISON PHARMACEUTIQUE DE PROGESTERONE ET D'ACIDE FOLIQUE | Entry into regional phase | 22.08.2001 | National basic fee paid | 22.08.2001 | Designation fee(s) paid | 22.08.2001 | Examination fee paid | Examination procedure | 29.08.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 22.08.2001 | Examination requested [2001/44] | 09.03.2004 | Despatch of a communication from the examining division (Time limit: M04) | 19.07.2004 | Reply to a communication from the examining division | 16.02.2005 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2005 | Reply to a communication from the examining division | 28.12.2005 | Despatch of a communication from the examining division (Time limit: M04) | 08.05.2006 | Reply to a communication from the examining division | 27.10.2006 | Communication of intention to grant the patent | 06.03.2007 | Fee for grant paid | 06.03.2007 | Fee for publishing/printing paid | 03.04.2007 | Despatch of a communication from the examining division (Time limit: M04) | 06.06.2007 | Reply to a communication from the examining division | Opposition(s) | 06.05.2008 | No opposition filed within time limit [2008/28] | Fees paid | Renewal fee | 29.01.2002 | Renewal fee patent year 03 | 30.01.2003 | Renewal fee patent year 04 | 30.01.2004 | Renewal fee patent year 05 | 27.01.2005 | Renewal fee patent year 06 | 26.01.2006 | Renewal fee patent year 07 | 31.01.2007 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2009/37] | IT | 28.01.2008 | Cited in | International search | [Y]GB2131292 (MORTIMER DR CHRISTOPHER H) [Y] 1-16 * abstract *; | [X] - BARNABEI V.M. ET AL, "Plasma homocysteine in women taking hormone replacement therapy: The postmenopausal Estrogen/Progestin Interventions (PEPI) trial.", JOURNAL OF WOMEN'S HEALTH AND GENDER-BASED MEDICINE, (1999) 8/9 (1167-1172)., XP000913564 [X] 1-16 * abstract * | [Y] - RHODE ET AL, "Effect of Orange Juice, Folic acid, and Oral Contraceptives on Serum Folate in Women taking a Folate-Restricted Diet", JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION,US,AMERICAN COLLEGE OF NUTRION, WILMINGTON, NC, (1983), vol. 2, no. 3, ISSN 0731-5724, pages 221 - 230-230, XP002114784 [Y] 1-16 * abstract * | [X] - BUTTERWORTH ET AL, "Improvement in Cervical Dysplasia Associated with Folic Acid Therapy in Users of Oral Contraceptives", AMERICAN JOURNAL OF CLINICAL NUTRITION,US,BETHESDA,MD, (198201), vol. 35, no. 1, pages 73 - 82-82, XP002114785 [X] 1-16 * abstract * | [X] - WHITEHEAD ET AL, "Megaloblastic Changes in the Cervical Epithelium. Association with Oral Contraceptive Therapy and Reversal with Folic acid", JAMA THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,US,CHICAGO,IL, (19731217), vol. 226, no. 12, ISSN 0098-7484, pages 1421 - 1424-1424, XP002114786 [X] 1-16 * abstract * DOI: http://dx.doi.org/10.1001/jama.226.12.1421 | Examination | WO0038691 | WO0051596 |